CardiaTec Biosciences is a seed startup. 1 investor tracked. Status: possibledead.
CardiaTec Biosciences is a startup founded in 2021 based in the United Kingdom. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
CardiaTec Biosciences applies artificial intelligence to large-scale multi-omic data to develop next-generation cardiovascular disease drug targets, leveraging human multi-omics data to better understand complex disease biology and identify novel therapeutics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.